Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial.
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
This study sought to investigate potential protective effects of atorvastatin in patients
with acute coronary syndromes (ACS) undergoing percutaneous coronary intervention
(PCI).